EICHORPublic-registry site landscape for NCT07643220, “Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions”, a Moderate-to-severe Benign Prostatic Hyperplasia (BPH) study sponsored by AJU Pharm Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07643220 (registry record) |
| Study title | Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions |
| Official title | An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-G721" and "G721R" in Healthy Adult Male Subjects |
| Sponsor | AJU Pharm Co., Ltd. |
| Condition(s) | Moderate-to-severe Benign Prostatic Hyperplasia (BPH) |
| Phase | PHASE1 |
| Listed sites | 1 |
| Intervention(s) | Test Drug, Reference Drug |
| Site countries | South Korea |
Patient-friendly overview of this study: eichor.com/study/NCT07643220.
Eichor generates a preliminary site-risk snapshot for NCT07643220 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
